Cingulate Q2 FY26 net loss widens to $5.87 million; SG&A more than doubles to $3.93 million
Reuters2026/08/13 12:32- Cingulate posted a Q2 net loss of USD 5.9 million, widening from USD 5 million a year earlier.
- RD expense fell 44.9% to USD 1.5 million, while SGA more than doubled to USD 3.9 million.
- Cash and cash equivalents rose to USD 28.4 million at June 30 from USD 11 million at Dec. 31.
- FDA issued a complete response letter on June 1 seeking additional CMC information for CTx-1301; no clinical safety or efficacy concerns were cited.
- Signed an exclusive services agreement with Prasco to set up commercial distribution; cash expected to fund operations into mid-2027.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The first major "exam" after the Cook era! Morgan Stanley: Apple's (AAPL.US) autumn launch event is the most important in ten years; the first foldable iPhone may spark a new wave of growth
Morgan Stanley analysts stated that Apple's upcoming "Surprise and Shine" autumn product launch event on September 9 may become the company's most important product release in nearly a decade.
For the first time in over a year, the open interest share of altcoins has surpassed that of bitcoin.
OPEC+ agrees to keep oil output policy unchanged for October
US military strikes Iranian oil tanker, triggering geopolitical risks as Brent crude nears $97 mark
Following the US military's attack on Iranian oil tankers and Iran's announcement of new restricted navigation zones outside the Strait of Hormuz, market concerns over prolonged disruptions in key energy transport routes have intensified, leading to a sharp rise in international oil prices.
Crypto prices
More
